News

New pulmonological protocols: participation in the study of a new therapy for chronic refractory cough is proposed

Successfully passed the visit of the selection center to participate in the study of a new medicine for the treatment of ulcerative colitis, the sponsor of the study is the pharmaceutical company Salix Pharmaceuticals

Screening of patients for the TT-06 clinical trial, sponsored by Alk-Abello, has been properly completed

Our Study Site is open to recruiting patients for a phase III clinical trial in order to evaluate the efficacy and safety of a new oral medicine for patients with moderate or severe Crohn's disease, sponsored by the pharmaceutical company Selgene, Switzerland.